Filing Flows › IQVIA Holdings (IQV) › Recalls, complaints & regulation
IQVIA Holdings (IQV): clinical trials and Federal Register
IQVIA Holdings (IQV) beyond its filings: 1 Federal Register document in a year; 1 active clinical trial.
IQVIA Holdings' latest quarter
IQVIA Holdings, Q3 2026: revenue $4.4B (+8% year over year), operating margin 12.9%, net earnings $352M, operating cash flow $825M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does IQVIA Holdings have?
1 active study on ClinicalTrials.gov, 0 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.